provided preliminary data on fungal keratitis (73/10000 annually), chronic obstructive pulmonary disease contributing to invasive Aspergillosis ( 1119 cases annually) , in addition to highlighting the overall prevalence of ABPA, chronic pulmonary Aspergillosis, and oral and esophageal candidiasis in HIV/AIDS patients. There are only scanty documentations on emerging fungal diseases in Nepal. However, Supram HS et al [2] from Manipal Teaching Hospital, Pokhara in Western Nepal recently reported invasive infections in a group of hospitalized patients caused by Magnusiomyces capitatus, an emerging yeast. It is, therefore, needless to emphasize that there is a significant burden of existing as well as emerging fungal diseases in Nepal. It is high time that epidemiological studies be conducted to validate these issues.
